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Introduction
Oxidative stress is an important part of a wide range of
pathologies and therefore an interesting parameter to
determine. However, the detection of reactive oxygen
species (ROS), is not straightforward. Sample heteroge-
neity, delayed analysis and sample preparation, reduces
specificity and sensitivity due to probe activation by
light, air, probe leakage from cells or cellular activation
by sample manipulation. Hence, samples should be pro-
cessed minimally and analysed immediately if possible.
Since clinical research can be subject to uncontrollable
timetables and only few departments have access to a
dedicated laboratory, the quantification of ROS is
challenging.
Objectives
For the purpose of a randomized-controlled trial invol-
ving Coronary Artery Bypass Graft surgery (CABG), we
sought to establish a flow cytometric assay to detect
ROS production in granulocytes (PMN) that is easy to
perform, does not require a specialised laboratory on-
site and is relatively insensitive to delay between sample
preparation and analysis. The fluorescent probe applied
is CellROX® Green (CrX; Life Technologies, Eugene,
Oregon, USA), which becomes fluorescent after oxida-
tion and subsequently binds to DNA.
Methods
Whole blood samples were collected from healthy
volunteers and from patients before (baseline) and dur-
ing CABG surgery (after 1 hour of cardiopulmonary
bypass, CPB). 30 µl whole blood was incubated for
1 hour with 10µM CrX immediately after sampling. To
compensate for the surgery induced PMN count
increase, 1 hour CPB samples were incubated with 10,
20 and 30µM CrX. Following incubation, erythrocytes
were lysed by hypotonic shock and the sample was
washed three times with Phosphate Buffered Saline
(PBS). Finally, leukocytes were stored in 200µl of PBS at
room temperature, in the dark, until analysis. Positive
and negative controls were obtained by additional incu-
bation with phorbol-12-myristate-13-acetate and
N-acetyl-cysteine. Mean Fluorescence Intensity (MFI) of
the PMN population, which is proportional to the ROS
produced, was measured in the FL1 channel of a BD
FACSCalibur as soon as possible after incubation of the
second CABG sample (~5 hours). PMN were identified
based on their forward and sideward scatter characteris-
tics to avoid fluorescence compensation corrections and
aspecific activation of neutrophils by fluorescent cell-
specific antibodies.
Results
In line with our expectations, little production of ROS
was demonstrated in healthy volunteers (n = 4) and base-
line samples from CABG surgery patients, while a
marked increase was found after one hour of CPB (n = 8,
figure 1). PMA induces a NAC-inhibitable increase of
MFI in CABG baseline samples. Interestingly, we were
also able to detect what appears as separate ROS produ-
cing neutrophil populations, which warrants further
investigation.
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Conclusions
Our current method is easy to perform, implementable
into clinical research and is able to detect different ROS
responses.
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